Contents hide 1 Non-Small Cell Lung Cancer 2 Dosage Modifications 2.1 Dose reduction increments Ceritinib is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). Non-Small Cell Lung Cancer Indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test 450 mg PO qDay with food Continue until disease progression or unacceptable toxicity Also see administration Dosage Modifications Dose reduction increments Starting dose: 450 mg qDay First dose reduction: 300 mg qDay Second dose reduction: 150 mg qDay Unable to tolerate 150 mg/day: … Continue reading Generic (Ceritinib) Cerini